The Effectiveness of Portable Electronic Vision Enhancement Systems (p-EVES) for Near Vision in Visual Impairment
NCT ID: NCT01701700
Last Updated: 2018-12-04
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
100 participants
INTERVENTIONAL
2013-02-28
2015-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The proposed study is a two-arm randomised crossover trial with existing users of optical magnifiers being assigned to use a hand-held electronic magnifier in addition to their existing devices for 2 months. Reading and task performance will be measured with the aid, and compared to the performance with optical aids, and the patient will be asked to report on the comparisons between the aids.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Visual and Functional Assessment in Low Vision Patients
NCT01876147
Influence of Low Vision Assistive Technology on Mobility Among Visually Impaired Individuals
NCT07055646
EFFECT:Eccentric Fixation From Enhanced Clinical Training
NCT01499628
Development of an ICT Platform-Awareness System for the Support of Low Vision
NCT05184036
Retina Projection System Trials for Low Vision People
NCT00219427
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
portable electronic magnifier
Use of a prescribed electronic magnifier plus existing optical aids for a period of 2 months
portable electronic magnifier
optical aids
optical aids
Use of existing optical aids for 2 months
optical aids
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
portable electronic magnifier
optical aids
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Visual impairment secondary to range of stable ocular pathologies (no change in VA \> 2 lines in previous 6 months)
* Currently possess a near vision optical magnifying device.
* VA \<= 6/30 (\<=0.7 logMAR) and/or log contrast sensitivity \<=1.20
Exclusion Criteria
* Hearing inadequate to respond to verbal instruction
* Habitual language not English
* A physical disability preventing the participant from operating the device
* A score of less than 19 on the Mini-Mental State Examination
18 Years
95 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Institute for Health Research, United Kingdom
OTHER_GOV
University of Manchester
OTHER
Cardiff University
OTHER
Bangor University
OTHER
Manchester University NHS Foundation Trust
OTHER_GOV
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Chris M Dickinson, PhD
Role: PRINCIPAL_INVESTIGATOR
University of Manchester
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Manchester Royal Eye Hospital
Manchester, , United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
R01715
Identifier Type: OTHER
Identifier Source: secondary_id
PB-PG-0211-24105
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.